Exact FDA event identifier

Event 79210

1 recalled-product record grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: February 13, 2018
Product types: Drug
Classifications: Class III
Statuses: Terminated
Recalling firm wording: Nostrum Laboratories Inc

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Calcium Acetate Capsules, 667 mg, 200 Capsules per bottle, Rx Only. Manufactured by Nostrum Laboratories, Inc. Kansas City, MO 64120. NDC 29033-026-02

D-0473-2018

Recall number: D-0473-2018
Initiated: February 13, 2018
Classification: Class III
Status: Terminated
Recalling firm: Nostrum Laboratories Inc
Quantity: 1,439,000 oral capsules

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0

Foreign Tablets

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Presence of Foreign Tablets/Capsules

Code information

Lot: CAL173502; Exp. 09/19

Distribution pattern

Nationwide